JWH-359
Overview[edit | edit source]
JWH-359 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is part of the JWH series of compounds, which were developed by Dr. John W. Huffman and his team in the 1990s. JWH-359 is primarily known for its high affinity for the CB2 receptor, which is predominantly found in the immune system.
Chemical Structure[edit | edit source]
JWH-359 is a member of the naphthoylindole family of synthetic cannabinoids. Its chemical structure is characterized by a naphthoyl group attached to an indole core. The specific configuration of JWH-359 allows it to interact selectively with cannabinoid receptors, particularly the CB2 receptor.
Pharmacology[edit | edit source]
JWH-359 exhibits a high selectivity for the CB2 receptor over the CB1 receptor, which is primarily located in the central nervous system. This selectivity makes it of interest for research into anti-inflammatory and immunomodulatory effects, as CB2 receptor activation is associated with modulation of immune responses.
Mechanism of Action[edit | edit source]
JWH-359 acts as a full agonist at the CB2 receptor, meaning it binds to the receptor and activates it to produce a biological response. This activation can lead to various effects, including the modulation of cytokine release and the inhibition of inflammatory pathways.
Potential Applications[edit | edit source]
Due to its selectivity for the CB2 receptor, JWH-359 has been studied for potential therapeutic applications in conditions such as autoimmune diseases, chronic pain, and neurodegenerative disorders. However, its use is limited to research settings, and it is not approved for medical use.
Legal Status[edit | edit source]
JWH-359, like many synthetic cannabinoids, is subject to legal restrictions in many countries. It is often classified as a controlled substance due to its potential for abuse and lack of approved medical use.
Safety and Toxicity[edit | edit source]
The safety profile of JWH-359 is not well-established, as it is primarily used in research. Synthetic cannabinoids, in general, can have unpredictable effects and may pose health risks, including cardiovascular and neurological effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
